ArticleFrontiers in pediatrics2025
Epidemiological characteristics and disease burden of childhood neuroblastoma in Asia: trends and regional differences over the past 30 years.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuroblastoma (NB) is the most common extracranial solid tumor in children, with significant clinical heterogeneity. Despite Asia's large pediatric population, comprehensive studies on its disease burden remain limited. Objective: This study aims to evaluate trends in NB disease burden among Asian children (0-14 years) from 1990 to 2021, examining age, sex, and socioeconomic variations. Methods: Using Global Burden of Disease (GBD 2021) data, we analyzed incidence, prevalence, deaths, and disability-adjusted life years (DALYs). Statistical analysis was performed using R (v4.5.0), with stratification by Socio-Demographic Index (SDI), age, and sex. Spatial distribution and annual percentage changes were visualized using ggplot2 and heatmaps. Results: From 1990 to 2021, NB burden increased significantly across Asia. Males showed higher burden than females, with infants (1-11 months) at greatest risk. East Asia experienced the fastest growth, while South Asia had the highest absolute burden. High-SDI regions demonstrated declining trends of disease burden but maintained the highest case numbers. Country-level variations were substantial, with Qatar and Afghanistan showing the largest increases and Kyrgyzstan the greatest reductions. SDI correlated positively with NB burden, suggesting improved detection in developed regions. Females exhibited bimodal incidence peaks (6-11 months and 5-9 years), while males peaked at 1-5 months and 2-4 years. Conclusion: The burden of NB in Asian children is characterized by age and gender differences and socioeconomic drivers. It is necessary to optimize screening and resource allocation strategies for high-risk groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.